Browse studies
Find your next paid study
2 recruiting studies matching your filters
Phase 1
A Phase 1 Study of SynKIR-310, Autologous T Cells Transduced With CD19 KIR-CAR, in Participants With Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma
This first-in-human (FIH) trial is designed to assess the safety, feasibility and preliminary efficacy of a single intravenous (IV) dose of SynKIR-310 administ…
B Cell LymphomaNHL, AdultMantle Cell Lymphoma+23 more
Verismo TherapeuticsNCT06544265
Phase 1
A Pilot Study Evaluating the Safety and Efficacy of Mosunetuzumab Consolidation Therapy After Autologous Stem Cell Transplantation in Patients With Relapsed/Refractory Aggressive B Cell Lymphoma
This phase 1 pilot study examines the feasibility and safety of mosunetuzumab after autologous stem cell transplant for patients with aggressive B cell lymphom…
B Cell LymphomaAggressive LymphomaDiffuse Large B Cell Lymphoma+3 more
Washington University School of MedicineNCT05412290